WO2003020933A1 - Nouvelle proteine mt0039 inhibitrice de serine protease - Google Patents

Nouvelle proteine mt0039 inhibitrice de serine protease Download PDF

Info

Publication number
WO2003020933A1
WO2003020933A1 PCT/JP2002/008948 JP0208948W WO03020933A1 WO 2003020933 A1 WO2003020933 A1 WO 2003020933A1 JP 0208948 W JP0208948 W JP 0208948W WO 03020933 A1 WO03020933 A1 WO 03020933A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
serine protease
protease inhibitory
inhibitory protein
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/008948
Other languages
English (en)
French (fr)
Inventor
Mikihiko Shinozaki
Yoshitaka Hosaka
Mutsuo Nanba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to EP02762987A priority Critical patent/EP1433848A4/en
Priority to US10/488,550 priority patent/US20050043254A1/en
Priority to CA002459272A priority patent/CA2459272A1/en
Publication of WO2003020933A1 publication Critical patent/WO2003020933A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/JP2002/008948 2001-09-03 2002-09-03 Nouvelle proteine mt0039 inhibitrice de serine protease Ceased WO2003020933A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02762987A EP1433848A4 (en) 2001-09-03 2002-09-03 NOVEL PROTEIN MT0039 SERINE PROTEASE INHIBITOR
US10/488,550 US20050043254A1 (en) 2001-09-03 2002-09-03 Novel serine protease inhibitory protein mt0039
CA002459272A CA2459272A1 (en) 2001-09-03 2002-09-03 Novel serine protease inhibitory protein mt0039

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-266004 2001-09-03
JP2001266004 2001-09-03

Publications (1)

Publication Number Publication Date
WO2003020933A1 true WO2003020933A1 (fr) 2003-03-13

Family

ID=19092385

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008948 Ceased WO2003020933A1 (fr) 2001-09-03 2002-09-03 Nouvelle proteine mt0039 inhibitrice de serine protease

Country Status (4)

Country Link
US (1) US20050043254A1 (ja)
EP (1) EP1433848A4 (ja)
CA (1) CA2459272A1 (ja)
WO (1) WO2003020933A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002252266B2 (en) 2001-03-08 2007-03-29 Immunex Corporation Human serpin polypeptides
CA2623772A1 (en) * 2005-09-19 2007-03-29 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Modulation of glucocorticoid receptor expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6583269B1 (en) * 2000-12-18 2003-06-24 Lexicon Genetics Incorporated Human protease inhibitor and polynucleotides encoding the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ASKEW Y.S. ET AL.: "SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases", J. BIOL. CHEM., vol. 276, no. 52, December 2001 (2001-12-01), pages 49320 - 49330, XP002956377 *
BUISSON A. ET AL.: "Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta 1", FASEB J., vol. 12, no. 15, 1998, pages 1683 - 1691, XP002956378 *
See also references of EP1433848A4 *

Also Published As

Publication number Publication date
US20050043254A1 (en) 2005-02-24
CA2459272A1 (en) 2003-03-13
EP1433848A1 (en) 2004-06-30
EP1433848A4 (en) 2005-04-06

Similar Documents

Publication Publication Date Title
WO2001075087A3 (en) Subtilisin variants
WO2002031134A3 (en) Novel serine protease genes related to dppiv
EP0994190A3 (en) DNA conferring L-homoserine resistance to bacteria, and its use
WO2002006510A3 (en) Photoselection of nucleic acid ligands
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
NO20005428D0 (no) Varmelabil uracil-DNA-glykosylase samt anvendelse derav
WO2003040681A3 (de) Gene die für stoffwechselweg-proteine codieren
WO2002090524A3 (en) Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
WO2000004162A3 (en) Genes encoding sulfate assimilation proteins
EP0943686A3 (en) Protein participating in activation of nitrile hydratase,gene,plasmid and a process for producing an amide
WO2002012543A3 (de) Zweifarbiges fluorimetrisches proteaseassay
WO2003031620A1 (en) Novel class ii cytokine receptor
WO2002090300A3 (en) Nucleic acids and proteins with thioredoxin reductase activity
EP1757698A4 (en) POLYPEPTIDE WITH DNA POLYMERASE ACTIVITY
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
WO2001083754A3 (en) Cellular regulators of infectious agents and methods of use
ATE380823T1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
WO2002101035A1 (fr) Proteine du canal cation dependant du potentiel
WO2003031642A3 (en) lovE VARIANT REGULATOR MOLECULES
WO2004043981A3 (en) Nucleic acids and proteins with thioredoxin reductase activity
EP1788075A4 (en) MOST SUITABLE MICROORGANISM
WO2002062964A3 (en) Ap1 amine oxidase variants
WO2003060092A3 (en) Modified fatty acid hydroxylase protein and genes
WO2001016325A3 (en) Plant reproduction proteins
WO2002008424A1 (fr) Genes abca2 humain et de rat

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KR KZ LC LR LS LT LU LV MA MD MG MK MN MX MZ NO NZ OM PH PL PT RO RU SE SG SI SK SL TJ TM TN TR TT TZ UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2459272

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002762987

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002762987

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10488550

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2002762987

Country of ref document: EP